Coronavirus impact: light at the end of the tunnel for dividends?
Three stocks from our Income Boosters portfolio have issued positive trading updates in recent days. We look at the latest from Direct Line Insurance, Tate & Lyle and Hikma Pharmaceuticals.
The UK and much of Europe appear to be moving towards the end of lockdown. And although we'd suggest the recent rapid recovery in equity prices may have been too rapid, we remain firm believers that over the medium term, most businesses will recover from the coronavirus pandemic.
Against this backdrop, we've had encouraging updates from several of our Income Boosters stocks over the last week.
Direct Line: trading well, guidance confirmed
Motor and home insurer Continue reading our content…
Previous article
Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Direct Line Insurance Group
Income Boosters: 2 new dividend shares for 2023
We're adding two new stocks to our high yield portfolio and ditching two disappointing performers.
Income Boosters - Sept ‘22 portfolio update
The companies in our Income Boosters portfolio are chosen for their boring reliability and plenty of…
More on Hikma
Income Boosters: market beating yield in Q1
It's been a solid start to the year for our dividend portfolio, which now yields nearly…
Income Boosters: clinical growth and takeover rumours
Three of our Income Boosters have lifted their dividends this week, after reporting solid results and…
More on Tate & Lyle
Income Boosters: 9% dividend yield plus a new stock
Our Income Booster stocks have enjoyed a solid results season. But we've decided to take profits…
Income Boosters: 2022 portfolio review
Our high yield portfolio is on track to deliver a 5.9% dividend yield in 2023, substantially…
